CVS Health Stock-Based Compensation — Historical Data
CVS Health (CVS) stock-based compensation was $535M in FY2025 (-1% YoY). The tables below show the complete quarterly and annual stock-based compensation history, sourced from SEC EDGAR 10-K and 10-Q filings.
Annual Stock-Based Compensation
Fiscal Year
Stock-Based Compensation
YoY
2025
$535M
-1%
2024
$540M
-8%
2023
$588M
+32%
2022
$447M
-8%
2021
$484M
+21%
2020
$400M
-12%
2019
$453M
+62%
2018
$280M
+20%
2017
$234M
+5%
2016
$222M
-3%
2015
$230M
+39%
2014
$165M
+17%
2013
$141M
+7%
2012
$132M
-2%
2011
$135M
-10%
2010
$150M
-9%
2009
$165M
+79%
2008
$92M
+18%
2007
$78M
Recent Quarterly Stock-Based Compensation
Quarter
Stock-Based Compensation
Q2 2026
$176M
Q1 2026
$266M
Q4 2025
$135M
Q3 2025
$138M
Q2 2025
$136M
Q1 2025
$126M
Q4 2024
$137M
Q3 2024
$133M
Q2 2024
$133M
Q1 2024
$137M
Q4 2023
$127M
Q3 2023
$154M
Source: CVS on EDGAR. Data from SEC EDGAR 10-K and 10-Q filings. Updated quarterly.